4//SEC Filing
MEDNAX, INC. 4
Accession 0001181431-13-032544
$MDCIK 0000893949operating
Filed
Jun 3, 8:00 PM ET
Accepted
Jun 4, 5:15 PM ET
Size
6.5 KB
Accession
0001181431-13-032544
Insider Transaction Report
Form 4
Clark David A.
COO / Pediatrix Division
Transactions
- Sale
Common Stock
2013-06-03$91.01/sh−8,645$786,781→ 15,887 total - Award
Common Stock
2013-06-01+6,867→ 24,532 total
Footnotes (3)
- [F1]Restricted shares granted pursuant to the Issuer's Amended and Restated 2008 Incentive Compensation Plan in connection with annual equity award. The vesting of the restricted shares is subject to performance based criteria but will not vest any earlier than in three equal installments on June 1, 2014, June 1, 2015 and June 1, 2016.
- [F2]Sales of shares were made pursuant to Reporting Person's 10b5-1 trading plan.
- [F3]Sales of shares were executed in fifty-nine (59) separate transactions with prices ranging from $90.32 to $92.34 for a weighted average sale price of $91.0099.
Documents
Issuer
MEDNAX, INC.
CIK 0000893949
Entity typeoperating
IncorporatedFL
Related Parties
1- filerCIK 0000893949
Filing Metadata
- Form type
- 4
- Filed
- Jun 3, 8:00 PM ET
- Accepted
- Jun 4, 5:15 PM ET
- Size
- 6.5 KB